37 results about "Magnolia amoena" patented technology

The invention discloses health-care tea for relieving radiotherapeutic complications, aims at reducing the occurrence rate of radiotherapeutic complications and belongs to the field of health-care foods. The health-care tea is characterized by being prepared in the following steps: (1) respectively distilling lycopodium, rhizoma kaempferiae, pawpaw, rhizoma phragmitis and magnolia amoena coarse powder with vapor to extract volatile oil, collecting and mixing the volatile oils for later use, and taking the medicinal residues for later use; (2) crushing tea, screening through a 60-mesh screen, and powdering for later use; (3) performing water extraction and alcohol precipitation on cynachum uilfordii hemsl, Yunnan bulbophyllum herb, Chinese usnea, asterina pectinifera, sargassumthunbergii o.kuntze, fistular onion stalk and the medicinal residues in the step (1); (4) concentrating and cooling the supernate obtained in the step (3), adding the mixed volatile oil in the step (1), and uniformly mixing to obtain a primary material; (5) drying and crushing the primary material obtained in the step (4), screening through a 100-mesh screen, adding the fine powder obtained in the step (2), sterilizing and subpacking into tea bags. The health-care tea for relieving radiotherapeutic complications has the characteristics of good effect and high safety, and is worthy of application and popularization.

The invention discloses a composition for prenatal care and aims to implement prenatal care intervention. The composition is characterized by comprising the following active pharmaceutical ingredients in parts by weight: Bulbophyllum inconspicuum Maxim, unpleasant swallowwort herb, Magnolia amoena, Sargassumthunbergii, lychee seed, yellow gelatin, Tetrapanax papyriferum, poncirus bark, common nostoc, dendrobe, sun-lo and fistular onion stalk. The clinical experiment proves that the composition for prenatal care is suitable for prenatal application, has the characteristics of favorable curative effect and high safety, and is worthy of clinical application and popularization.

The invention discloses a preparation method of powder for treating atrophic vaginitis, aiming at solving the problem in treating atrophic vaginitis. The preparation method is characterized by comprising the following steps of: (1) carrying out reduced pressure distillation on crude powder of himalayan coralbean bark, ternate buttercup root and ephedra root and extracting volatile oil; (2) carrying out reduced pressure boiling on the volatile oil to obtain a filtrate; (3) boiling Trikeraia hookeri, Magnolia amoena, parasitic loranthus, coked malt, coked medicated leaven, spina gleditsiae, peach gum, cassia twig and the medicinal filtrate obtained in the step (1) so as to obtain a filtrate for later use; (4) combining the filtrates in the steps (2) and (3), carrying out reduced pressure concentration so as to obtain a dry extract, and crushing the dry extract to obtain dry extract powder; (5) ejecting the volatile oil obtained in the step (1) into the dry extract powder obtained in the step (4), uniformly mixing, screening in a sieve of 100 meshes and sub-packaging so as to obtain the powder. Clinical trial shows that the powder has the characteristics of being good in effect on treating atrophic vaginitis and high in security, and is worthy of clinical application and popularization.

The invention discloses a capsule for treating diabetic kidney damage for solving the problem in treatment of the diabetic kidney damage. The capsule is characterized in that a preparation method of the capsule comprises the following steps of: (1) carrying out steam distillation on gastrodia fruit, malva seed and Chinese taxillus twig to extract volatile oil for later use and reserving the dregs for later use; (2) smashing erythrina indica lam and parched rice sprout into fine powder for later use; (3) uniformly mixing fructus cannabis, magnolia amoena, trifoliate orange bark scrap, allium victorialis, catclaw buttercup root, Chinese starjasmine stem, cassia twig with the dregs obtained in the step (1), carrying out ethanol extraction twice, combining the two-time alcohol extract, filtering, recovering ethyl alcohol and concentrating into extract under reduced pressure; and (4) adding the extract obtained in the step (3) into the fine powder obtained in the step (2), uniformly mixing, drying at the temperature of 60 DEG C, smashing into fine powder, adding polysorbate-80, pelleting, drying, stabilizing size, spraying the volatile oil obtained in the step (1), uniformly mixing, and finally encapsulating. Proved by clinical experiments, the capsule for treating the diabetic kidney damage, disclosed by the invention, has the characteristics of good treatment effect and high safety and is worthy of clinical application and popularization.

The invention discloses a method for preparing granules for treating alcoholic cardiomyopathy arrhythmia. The granules are applied to the therapy of alcoholic cardiomyopathy. The method is characterized by comprising the steps of (1) distilling Litchi chinensis Sonn., Stachys kouyangensis(Van.) Dunn and Aeschynomene indica L. by water vapor, so as to extract volatile oil for later use, and enabling dregs to be standby; (2) crushing Gekko gecko Linnaeus and Setaria italica (L.) Beauv. into fine powder for later use; (3) uniformly mixing Selaginella tamariscina (Beauv.) Spring, Begonia handelii Irmsch., Poncirus tuifoliata (L.) Raf., Polygonum aviculare L., Magnolia amoena Cheng, Dracocephalum moldavica L., Callicarpa nudiflora Hook. Et Arn. and the dregs obtained in the step (1), carrying out ethanol extraction twice, merging two alcohol extracts, filtrating, recovering ethanol, and carrying out depressurized concentration, so as to form an extract; (4) adding the fine powder obtained in the step (2) into the extract obtained in the step (3), uniformly mixing, drying at the temperature of 60 DEG C, crushing into fine powder, adding polysorbate-80, granulating, drying, finishing, spraying the volatile oil obtained in the step (1), uniformly mixing, and packaging granules, thereby obtaining the granules. Proved by clinical trials, the granules have the characteristics of good treatment effect and relatively high safety in the therapy of alcoholic cardiomyopathy, so that the granules are worthy of clinical application and popularization.

The invention discloses a clysis liquid used for chronic renal failure, solving the problem of the treatment of chronic renal failure. The clysis liquid is prepared from the following raw medicines: erythrina indica lam, trikeraia hookeri, tetrapanax papyriferum, magnolia amoena, sangusis draconis, radix ranunculi ternate, caramel malt, medicated leaven, mussel, folium dalbergiae mimosoidis, prunus persica (L.) batsch and cassia twig. The clinical experiment result shows that the clysis liquid has the characteristics of high curative effect and relatively high safety on chronic renal failure treatment, and is worthy for clinical application and popularization.

The invention discloses a cutireaction intervention medicine after radiotherapy and a preparation method thereof, and aims to solve the problem of prevention of cutireaction after radiotherapy. The preparation method is characterized by comprising the following steps: (1) melting yellow gelatin with a fistular onion stalk decoction to prepare gelatin beads for later use; (2) extracting volatile oil from ivy glorybind herb root and herba siegesbeckiae, collecting, mixing for later use, and taking decoction dregs for later use; (3) carrying out water extraction and alcohol precipitation on Cynachum uilfordii Hemsl, chalcanthite, papaya, Bulbophyllum inconspicuum Maxim, Sargassumthunbergii, petrel, Reed Rhizome, Magnolia amoena and the decoction dregs obtained in the step 1, and taking the supernate; (4) adding the supernate obtained in the step 3 into the gelatin beads obtained in the step 1; addition the mixed volatile oil obtained in the step 2, and evenly mixing to obtain a primary material; and (5) drying the primary material obtained in the step 4, pulverizing, and passing through a 100-mesh screen to obtain the medicinal powder. The clinical experiment proves that the medicine has the characteristics of favorable curative effect and higher safety when being used for preventing cutireaction after radiotherapy, and is worthy of clinical application and popularization.